Home/Filings/4/0001209191-18-046392
4//SEC Filing

Driscoll Martin J 4

Accession 0001209191-18-046392

CIK 0001566373other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 4:04 PM ET

Size

4.6 KB

Accession

0001209191-18-046392

Insider Transaction Report

Form 4
Period: 2018-08-13
Driscoll Martin J
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2018-08-13$12.02/sh+4,000$48,08060,400 total

Issuer

Spring Bank Pharmaceuticals, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001339402

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:04 PM ET
Size
4.6 KB